IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue273,957149,55576,436
Cost of Revenue1,868125,291
Gross Profit272,089149,54371,145
Operating Expenses
Research Development139,492108,746101,890
Selling General and Administrative183,112125,247118,333
Non Recurring37417,63820,292
Others981981981
Total Operating Expenses323,959--
Operating Income or Loss-51,870-102,088-169,370
Income from Continuing Operations
Total Other Income/Expenses Net9,315-9,485918
Earnings Before Interest and Taxes-42,555-111,573-168,452
Interest Expense39,15331,09621,166
Income Before Tax-81,708-142,669-189,618
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-81,708-142,669-189,618
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-81,708-142,669-189,618
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-81,708-142,669-189,618